FX Contra
K-Number: K222518 · 2022-11-17
Device Summary
Frequently Asked Questions
What is the FX Contra?
FX Contra is a medical device that received FDA 510(k) clearance on 2022-11-17. The listed applicant is Nakanishi, Inc.. The 510(k) number is K222518.
When did FX Contra receive FDA 510(k) clearance?
FX Contra received FDA 510(k) clearance on 2022-11-17, under 510(k) number K222518.
Who is the listed applicant for FX Contra?
The FDA 510(k) record lists Nakanishi, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for FX Contra?
The FDA product code for FX Contra is EGS.
Other records listing Nakanishi, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: EGS)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.